Design
Review
Answers are grounded in this paper and cite their sources.
This review highlights the complex interplay of neuronal and non-neuronal mediators, particularly nitric oxide, in modulating sympathetic neurovascular transmission and its relevance to hypertension.
Noradrenaline, neuropeptide Y and adenosine triphosphate are co-stored in, and co-released from, sympathetic nerves. Each transmitter modulates its own release as well as the release of one another; thus, anything affecting the release of one of these transmitters has consequences for all. Neurotransmission at the sympathetic neurovascular junction is also modulated by non-sympathetic mediators such as angiotensin II, serotonin, histamine, endothelin and prostaglandins through the activation of specific pre-junctional receptors. In addition, nitric oxide (NO) has been identified as a modulator of sympathetic neuronal activity, both as a physiological antagonist against the vasoconstrictor actions of the sympathetic neurotransmitters, and also by directly affecting transmitter release. Here, we review the modulation of sympathetic neurovascular transmission by neuronal and non-neuronal mediators with an emphasis on the actions of NO. The consequences for co-transmission are also discussed, particularly in light of hypertensive states where NO availability is diminished.
No takes yet. Share an insight, caveat, or question.
Macarthur et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: